Moelis Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Moelis (NYSE:MC) earned $3.56 million, a 84.28% increase from the preceding quarter.…

According to Benzinga Pro, during Q1, Moelis (NYSE:MC) earned $3.56 million, a 84.28% increase from the preceding quarter. Moelis’s sales decreased to $185.30 million, a 8.33% change since Q4. Moelis earned $22.67 million, and sales totaled $202.14 million in Q4.

What Is ROCE?

Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company’s ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q1, Moelis posted an ROCE of 0.01%.

Keep in mind, while ROCE is a good measure of a company’s recent performance, it is not a highly reliable predictor of a company’s earnings or sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Moelis is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For Moelis, the positive return on capital employed ratio of 0.01% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.

Analyst Predictions

Moelis reported Q1 earnings per share at $0.05/share, which did not meet analyst predictions of $0.1/share.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Pervasip Reports Slight YoY Decrease In Q1 Revenue As It Prepares For Cannabis Spin-Off

Pervasip announced on Tuesday its 2024 first-quarter financial results. Simultaneously, the Seattle, Washington-based company said it's still in the restructuring process and preparation for the spin-out of all of its cannabis assets. "We are entering our final phase of restructuring which involves making difficult decisions to ensure additional expense reductions and separating the company from assets it has held for many years," German Burtscher, Pervasip's president and chief executive officer, said. Additionally, as part of the restructuring, George Jordan has resigned from his duties as CFO and COO of the company and will stay on as an advisor, supporting management through its final phase of changes in preparation for the spin-out of Artizen Corporation.

PVSP